Table 2.
Protein components of paraspeckles (NEAT1 interactors) genetically linked to ALS/FTD.
| Protein | Importance for paraspeckle assembly | Regulation of NEAT1_2 levels | Role in ALS | Role in other neurodegenerative diseases |
|---|---|---|---|---|
| FUS | Essential, >75% loss upon knockdown [37,45] | No or minimal | >50 mutations in fALS and sALS; FUS proteinopathy in these cases [143,144] | FTD (FTLD-FUS) [145] |
| TDP-43 | Depletion enhances paraspeckle assembly [30] | Yes (more NEAT1_2 upon TDP-43 depletion) | >60 mutations in fALS and sALS; TDP-43 proteinopathy in cases with TARDBP and C9ORF72 mutations and in 95% of all sALS cases [110,144,146] | FTD (FTD-TDP) [146]; AD [147] |
| TAF15 | Important, 30–75% loss upon knockdown [37] | No | 6 mutations in 6 unrelated sALS cases and 2 mutations – in 2 fALS cases [148,149] | FTD (FTD-FUS) [150] |
| EWS | Important, 30–75% loss upon knockdown [37] | Yes | 2 mutations in 2 unrelated sALS cases [151] | FTD (FTD-FUS) [150] |
| hnRNPA1 | Important, 30–75% loss upon knockdown [37] | No | 2 mutations in fALS cases; 2 rare variants [152,153] | Multisystem proteinopathy (MSP) [152] |
| CRESTa | ND | ND | 4 mutations in 4 unrelated sALS cases [154,155] | N/A |
| MATR3 | Depletion enhances paraspeckle assembly [156] | Yes (more NEAT1_2 upon MATR3 depletion) | ∼10 mutations in fALS and sALS cases [157,158] | Initially diagnosed myopathy with vocal cord paralysis, diagnosis changed to ‘ALS’ [159] |
| SFPQ | Essential, >75% loss upon knockdown [37] | Yes | 2 mutations in 2 sALS cases [160] | N/A |
neurospecific, effect on paraspeckles in stable cell lines could not be tested.